“In-Depth In Silico Investigation Of Gitalin And Glaziovine As Possible VEGFR-2 Kinase Inhibitors For The Treatment Of Cancer”, Journal of Pharmaceutical Negative Results, pp. 6523–6531, Dec. 2022, doi: 10.47750/.